Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 46001-46050 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05669092
A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status
PHASE3Recruiting
174 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05543785
Ketorolac Intravenous Regional Analgesia in Lower Limb Surgeries
NARecruiting
76 participants
Started: Nov 1, 2022 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05314946
Nutritional Support During Induction Therapy for Esophageal Cancer
NARecruiting
26 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05922540
a Cohort Study of Ischemic Cerebrovascular Disease
N/ARecruiting
5,000 participants
Started: Nov 1, 2022 · Completed: Nov 1, 2027
1 condition1 sponsor1 location
NCT05785780
Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings
NARecruiting
30 participants
Started: Nov 1, 2022 · Completed: Sep 30, 2025
2 conditions2 sponsors1 location
NCT06043921
Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel
N/ARecruiting
150 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06336174
Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study
N/ARecruiting
100 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT06023056
Hepatitis B Vaccination After Neonatal Surgery
N/ARecruiting
180 participants
Started: Nov 1, 2022 · Completed: Nov 1, 2030
5 conditions1 sponsor1 location
NCT05496582
The Association of Transgelin-2, Metallothionein-2 and Ezrin With Asthma
N/ARecruiting
100 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2026
1 condition3 sponsors2 locations
NCT05445804
Oral Cannabidiol for Tobacco Cessation
PHASE1Recruiting
50 participants
Started: Nov 1, 2022 · Completed: Feb 1, 2026
5 conditions2 sponsors1 location
NCT04117997
Validation Fugl-Meyer in Italian Language (FMI)
N/ARecruiting
70 participants
Started: Nov 1, 2022 · Completed: Dec 1, 2025
1 condition2 sponsors1 location
NCT05655754
Comparison of Esketamine/Propofol and Methohexital Anesthesia for ECT
PHASE4Recruiting
100 participants
Started: Nov 1, 2022 · Completed: Oct 31, 2025
2 conditions1 sponsor1 location
NCT05052086
Magnetomotoric Ultrasound (MMUS) in Rectal Cancer
NARecruiting
60 participants
Started: Nov 1, 2022 · Completed: Jan 1, 2025
1 condition1 sponsor1 location
NCT05305287
Quantifying Hepatic Mitochondrial Fluxes in Humans
PHASE4Recruiting
60 participants
Started: Nov 1, 2022 · Completed: Mar 31, 2027
3 conditions2 sponsors2 locations
NCT05254184
KRAS-Targeted Vaccine With Nivolumab and Ipilimumab for Patients With NSCLC
PHASE1Recruiting
12 participants
Started: Nov 1, 2022 · Completed: Apr 1, 2027
1 condition1 sponsor1 location
NCT05728216
Histopathological Analysis of Renal Biopsies With Dynamic Full-field Optical Coherence Tomography, a Comparison to Conventional Histopathological Findings for the Diagnosis of Either Acute Kidney Injury or Chronic Kidney Disease in Routine Practices (NEPHROCT)
N/ARecruiting
50 participants
Started: Nov 1, 2022 · Completed: Nov 30, 2025
3 conditions2 sponsors1 location
NCT05387603
Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors.
PHASE3Recruiting
300 participants
Started: Nov 1, 2022 · Completed: Oct 1, 2026
1 condition1 sponsor4 locations
NCT05404581
Insula Neuromodulation for Chronic Neuropathic Pain
NARecruiting
12 participants
Started: Nov 1, 2022 · Completed: Jun 29, 2027
2 conditions2 sponsors1 location
NCT05606263
Efficacy and Safety of Caldonirimab Plus Nimotuzumab for Recurrent or Metastatic Cervical Cancer
PHASE2Recruiting
55 participants
Started: Nov 1, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05846763
Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Follicular Lymphoma in Real World Study
N/ARecruiting
50 participants
Started: Nov 1, 2022 · Completed: May 31, 2028
1 condition1 sponsor1 location
NCT05734365
COPD-ICU Multicentre Prospective Observational Register
N/ARecruiting
500 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06529562
Surgery Plus Reduced Target Chemoradiotherapy vs Surgery Plus Reduced Dose Chemoradiotherapy for Newly Diagnosed Operable Nasopharyngeal Carcinoma.
NARecruiting
384 participants
Started: Nov 1, 2022 · Completed: Nov 1, 2032
1 condition8 sponsors1 location
NCT06206681
Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors
N/ARecruiting
1,000 participants
Started: Nov 1, 2022 · Completed: Sep 1, 2025
4 conditions1 sponsor1 location
NCT05518513
Continuous Infusion and Intermittent Bolus Adductor Canal Block for Total Knee Arthroplasty
NARecruiting
66 participants
Started: Nov 1, 2022 · Completed: Sep 30, 2024
2 conditions1 sponsor1 location
NCT06125262
Trajectory Analysis of NLR and Its Association With Efficacy of Immunochemotherapy in ESCC.
N/ARecruiting
100 participants
Started: Nov 1, 2022 · Completed: Jul 31, 2025
3 conditions1 sponsor1 location
NCT05876130
Postoperative Hypofractionated Intensity-modulated Radiotherapy Endometrial Cancer
NARecruiting
92 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2031
1 condition1 sponsor1 location
NCT05593679
A Multi-center Cardiac PYP Scan Registry in Taiwan
N/ARecruiting
1,000 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT04947189
Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer
PHASE1/PHASE2Recruiting
65 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06037993
Endocannabinoid Activity Remodulation for Psychosis Liability in Youth
NARecruiting
20 participants
Started: Nov 1, 2022 · Completed: Nov 30, 2025
3 conditions2 sponsors2 locations
NCT05583175
Venetoclax Plus RIC Regimen Allo-HSCT for Elderly Patients With High-risk Myeloid Malignancies
PHASE2Recruiting
50 participants
Started: Nov 1, 2022 · Completed: Nov 1, 2024
4 conditions1 sponsor1 location
NCT05750901
Evaluation of Fractional Ablative Laser Treatment for Skin Conditions
NARecruiting
1,000 participants
Started: Nov 1, 2022 · Completed: Jun 20, 2026
1 condition1 sponsor1 location
NCT04564482
PD-L1 PET Imaging During Neoadjuvant (Chemo)Radiotherapy in Esophageal and Rectal Cancer
NARecruiting
20 participants
Started: Nov 1, 2022 · Completed: Jun 1, 2026
2 conditions1 sponsor1 location
NCT05553197
Intersession Processes in Psychotherapeutic Treatments Using an Ecological Momentary Assessment Approach (ISA-Bell)
NARecruiting
84 participants
Started: Nov 1, 2022 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT05180097
Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma
PHASE2Recruiting
84 participants
Started: Nov 1, 2022 · Completed: Jun 30, 2026
1 condition4 sponsors18 locations
NCT07181070
The Use of Indocyanine Green Fluorescence (ICG) During Laparoscopic Heller- Dor
N/ARecruiting
70 participants
Started: Nov 1, 2022 · Completed: Oct 31, 2026
4 conditions1 sponsor1 location
NCT05473910
A Study of TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem Transplantation
PHASE1Recruiting
75 participants
Started: Nov 1, 2022 · Completed: Jun 30, 2026
3 conditions1 sponsor15 locations
NCT05544188
Functional Pathologies of the Musculoskeletal System in Physiotherapy Students
NARecruiting
60 participants
Started: Nov 1, 2022 · Completed: Jun 1, 2024
1 condition1 sponsor1 location
NCT05909436
Immuno-Oncology Drugs GLS-012 Alone & in Combination GLS-010 Treating With Advanced Patients Solid Tumors
PHASE1/PHASE2Recruiting
107 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05415111
The Adjunctive Effect of Soft Tissue Augmentation Procedures of Moderate-severe Peri-implantitis
NARecruiting
120 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2029
1 condition1 sponsor3 locations
NCT05531240
Transurethral Prostate Resection (TURP) vs. Prostate Artery Embolization (PAE)
NARecruiting
104 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2025
3 conditions5 sponsors4 locations
NCT05377723
Abdominal Scar Improvement in Microsurgical Breast Reconstruction
NARecruiting
100 participants
Started: Oct 31, 2022 · Completed: Oct 31, 2025
2 conditions1 sponsor1 location
NCT05593419
Selecting Patients Who May Benefit From Immunotherapy by Tissue-based Biomarkers.
N/ARecruiting
300 participants
Started: Oct 31, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT04612907
Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer
NARecruiting
420 participants
Started: Oct 31, 2022 · Completed: Sep 30, 2032
3 conditions1 sponsor1 location
NCT05354869
Transvaginal Electrical Stimulation for Myofascial Pelvic Pain
NARecruiting
60 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04927377
Accessible and Inclusive Diabetes Telecoaching Self-Management Program
NARecruiting
90 participants
Started: Oct 31, 2022 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT05707442
Stent Implantation Versus Medical Therapy for Idiopathic IntracraniaL Hypertension (SIMPLE)
PHASE3Recruiting
74 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05632588
Near Fatal Asthma in Children and Young People
N/ARecruiting
400 participants
Started: Oct 31, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT04020055
A Study to Evaluate Migalastat in Fabry Subjects With Amenable GLA Variant and Renal Disease
PHASE3Recruiting
14 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor15 locations
NCT06826092
Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy
PHASE2Recruiting
110 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05562427
Program for Fully Understanding Eating and Lifestyle Change (FUEL)
NARecruiting
150 participants
Started: Oct 31, 2022 · Completed: Apr 30, 2027
1 condition2 sponsors1 location